###begin article-title 0
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Loeys-Dietz syndrome type I and type II: clinical findings and novel mutations in two Italian patients
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 754 760 754 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1</italic>
###xml 770 776 770 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2</italic>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
###xml 866 874 <span type="species:ncbi:9606">patients</span>
Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder showing the involvement of cutaneous, cardiovascular, craniofacial, and skeletal systems. In particular, LDS patients show arterial tortuosity with widespread vascular aneurysm and dissection, and have a high risk of aortic dissection or rupture at an early age and at aortic diameters that ordinarily are not predictive of these events. Recently, LDS has been subdivided in LDS type I (LDSI) and type II (LDSII) on the basis of the presence or the absence of cranio-facial involvement, respectively. Furthermore, LDSII patients display at least two of the major signs of vascular Ehlers-Danlos syndrome. LDS is caused by mutations in the transforming growth factor (TGF) beta-receptor I (TGFBR1) and II (TGFBR2) genes. The aim of this study was the clinical and molecular characterization of two LDS patients.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
The exons and intronic flanking regions of TGFBR1 and TGFBR2 genes were amplified and sequence analysis was performed.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 343 350 343 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 362 370 362 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 723 730 723 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 16 19 <span type="species:ncbi:9606">boy</span>
###xml 425 432 <span type="species:ncbi:9606">Patient</span>
###xml 448 453 <span type="species:ncbi:9606">woman</span>
###xml 694 701 <span type="species:ncbi:9606">patient</span>
Patient 1 was a boy showing dysmorphic signs, blue sclerae, high-arched palate, bifid uvula; skeletal system involvement, joint hypermobility, velvety and translucent skin, aortic root dilatation, tortuosity and elongation of the carotid arteries. These signs are consistent with an LDSI phenotype. The sequencing analysis disclosed the novel TGFBR1 p.Asp351Gly de novo mutation falling in the kinase domain of the receptor. Patient 2 was an adult woman showing ascending aorta aneurysm, with vascular complications following surgery intervention. Velvety and translucent skin, venous varicosities and wrist dislocation were present. These signs are consistent with an LDSII phenotype. In this patient and in her daughter, TGFBR2 genotyping disclosed in the kinase domain of the protein the novel p.Ile510Ser missense mutation.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:405018">cardinal</span>
We report two novel mutations in the TGFBR1 and TGFBR2 genes in two patients affected with LDS and showing marked phenotypic variability. Due to the difficulties in the clinical approach to a TGFBR-related disease, among patients with vascular involvement, with or without aortic root dilatation and LDS cardinal features, genotyping is mandatory to clarify the diagnosis, and to assess the management, prognosis, and counselling issues.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 649 657 <span type="species:ncbi:9606">patients</span>
Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder characterized by hypertelorism, bifid uvula and/or cleft palate, and arterial tortuosity with widespread vascular aneurysm and dissection [1]. LDS shows the involvement of cutaneous, cardiovascular, craniofacial and skeletal systems [1,2]. LDS patients have a high risk of aortic dissection or rupture at an early age and at aortic diameters that ordinarily are not predictive of these events [2]. Recently, LDS has been subdivided in LDS type I (LDSI) and type II (LDSII) on the basis of the presence or the absence of cranio-facial involvement, respectively [2]. Furthermore, LDSII patients display at least two of the major signs of vascular Ehlers-Danlos syndrome (vEDS) [2].
###end p 11
###begin p 12
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1</italic>
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2</italic>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 266 274 266 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">habitus </italic>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 649 658 649 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spectrum </italic>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Mutations in the transforming growth factor (TGF) beta-receptor type I (TGFBR1) and type II (TGFBR2) genes have been found to cause LDS [1]. Mutations in these genes were also reported in other syndromes showing cardiovascular involvement, with or without marfanoid habitus or fulfilled Ghent criteria for Marfan syndrome (MFS) and variable association with signs characteristic of LDS: MFS type 2 (MFS2), Furlong syndrome (FS), familial thoracic aortic aneurysms and dissections type 2 (TAAD2), and Shprintzen-Goldberg syndrome, the nosological status of which is still controversial [3-9]. All these syndromes should be considered as a phenotypic spectrum associated with aberrant TGFbeta signalling [9].
###end p 12
###begin p 13
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
TGFBR1 and TGFBR2 are transmembrane serine/threonine kinases, both able to bind TGFbeta. Ligand binding mediates TGFbeta signalling activation [10]. They are composed of a small cysteine-rich extracellular domain, a single transmembrane region, and an intracellular kinase domain [10]. So far, less than 30 TGFBR1 and less than 100 TGFBR2 disease causing mutations have been described [1-6,11-13].
###end p 13
###begin p 14
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Here we report the characterization of two Italian LDS patients and the identification of two novel mutations, one in the TGFBR1 and the other in the TGFBR2 gene.
###end p 14
###begin title 15
Case Presentation
###end title 15
###begin p 16
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ratio </italic>
###xml 421 430 421 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">alae nasi</italic>
###xml 512 540 512 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pectus excavatum, pes planus</italic>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 1027 1034 <span type="species:ncbi:9606">patient</span>
Patient 1 was a seven years old male, born at term after uncomplicated pregnancy from non-consanguineous parents. At birth, weight and length were normal; he showed bilateral clubfoot and hand contractures characterized by camptodactyly and ulnar deviation. At the age of six years he showed: height 130.5 cm, arm span 129 cm, upper:lower segment ratio 0.89, muscular hypotrophy; dolicocephaly, blue sclerae, hypoplastic alae nasi, microretrognathia, high-arched palate, bifid uvula; mild thoracic scoliosis and pectus excavatum, pes planus, joint hypermobility (Beighton score 8/9); velvety and translucent skin (Fig. 1A). Echocardiogram showed bicuspid aortic valve, patent foramen ovale, mild interventricular septal hypertrophy without outflow obstruction, mild mitral valve prolapse, aortic root diameter 23 mm and ascending aorta diameter 21 mm. Magnetic Resonance Angiography (MRA) displayed tortuosity and elongation of the basilar and internal carotid arteries with kinking and coiling of these last. Furthermore, the patient suffered from allergic asthma and atopic dermatitis.
###end p 16
###begin p 17
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Clinical and radiographic features of the two LDS Patients</bold>
###xml 60 63 60 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 144 153 144 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">alae nasi</italic>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">habitus</italic>
###xml 248 258 248 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pes planus</italic>
###xml 260 263 260 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 302 303 302 303 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i</italic></bold>
###xml 418 420 418 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 418 420 418 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ii</italic></bold>
###xml 433 436 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
###xml 433 436 433 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>iii</italic></bold>
###xml 598 601 598 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 50 58 <span type="species:ncbi:9606">Patients</span>
###xml 76 83 <span type="species:ncbi:9606">Patient</span>
###xml 263 270 <span type="species:ncbi:9606">Patient</span>
###xml 667 674 <span type="species:ncbi:9606">Patient</span>
Clinical and radiographic features of the two LDS Patients. A) Phenotype of Patient 1, showing facial dysmorphisms: dolichocephaly, hypoplastic alae nasi, and micro/retrognathia; marfanoid habitus, muscular hypotrophy, mild thoracic scoliosis, and pes planus. B) Patient 2: Ascending aorta dilatation (i) and MRI axial T1 spin-echo images of the ascending aorta at the level of re-implanted coronary arteries, before (ii) and after (iii) gadolinium: a periaortic collection is visible (arrows), with contrast medium outside the aortic graft, due to detachment of re-implanted left coronary artery. C) Translucent skin with subcutaneous visible veins and flat feet in Patient 2.
###end p 17
###begin p 18
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 26 31 <span type="species:ncbi:9606">woman</span>
###xml 669 676 <span type="species:ncbi:9606">patient</span>
###xml 779 786 <span type="species:ncbi:9606">patient</span>
Patient 2, a 48 years old woman, underwent several vascular surgery interventions: at the age of 26 years vascular prosthesis replacement of the ascending aorta with Bentall technique (composite graft and coronary arteries reimplant) for aortic aneurysm; eight years later, surgery for haematoma consequent to suture dehiscence at the level of the left coronary ostium; at the age of 43 years surgical repair of acute dissection starting from the distal anastomosis of the aortic graft extended to the abdominal aorta; at the age of 44 years, endovascular treatment with stent-graft of the descending aorta for increase of descending thoracic false lumen (Fig 1B). The patient showed: height 165 cm, velvety and translucent skin, and bilateral venous varicosities (Fig. 1C). The patient had a total of two pregnancies, the first uncomplicated, the second terminated at about 4 months of gestation because of the presence of the above mentioned aneurysm of the ascending aorta at high dissection risk. She had recurrent wrist dislocations in childhood. Proband's father suddenly died at the age of 33 years for unknown causes. The 26 years old proband's daughter did not present valvular, aortic or other anomalies during several echocardiographic evaluations. Her clinical history included a pituitary adenoma and she suffered from reactive hypoglycaemia and allergic rhinitis. Recurrent left patella dislocations were reported, without other signs of joint hypermobility. She showed mild myopia.
###end p 18
###begin p 19
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 348 356 348 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 979 980 979 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 3 10 <span type="species:ncbi:9606">Patient</span>
###xml 366 373 <span type="species:ncbi:9606">Patient</span>
In Patient 1, sequencing analysis of genomic DNA disclosed in exon 6 of the TGFBR1 gene the c.1052A>G transition, leading to the substitution of an aspartic acid with a glycine in position 351 of the aminoacidic sequence (p.Asp351Gly) (Fig. 2A). This novel missense mutation was not detected in the proband's parents, suggesting that it arose as a de novo event. In Patient 2 and in her daughter, TGFBR2 genotyping disclosed the c.1529T>G transversion in exon 7, resulting in the p.Ile510Ser missense mutation (Fig. 2A). The proband's father was likely affected with LDS, as he suddenly died at a young age. Both missense mutations here identified were not detected in 250 chromosomes of control Italian blood donors, and substituted residues in the kinase domain of the proteins, which is highly conserved in the homologous of the receptor (Fig. 2B). Furthermore, in silico prediction algorithms, polymorphism phenotyping (PolyPhen) and sorting intolerant from tolerant (SIFT) [3], characterized both the p.Asp351Gly and p.Ile510Ser substitutions as damaging and affecting protein function, respectively.
###end p 19
###begin p 20
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Molecular characterization of the patients by <italic>TGFBR1 </italic>and <italic>TGFBR2 </italic>sequencing on genomic DNA, obtained from whole peripheral blood</bold>
###xml 129 132 129 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 233 240 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 375 382 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 438 441 438 441 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 590 597 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 601 608 601 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 157 164 <span type="species:ncbi:9606">Patient</span>
###xml 314 321 <span type="species:ncbi:9606">Patient</span>
###xml 501 509 <span type="species:ncbi:9606">patients</span>
Molecular characterization of the patients by TGFBR1 and TGFBR2 sequencing on genomic DNA, obtained from whole peripheral blood. A) Sequence chromatogram of Patient 1, showing the position of the heterozygous c.1052A>G transition in TGFBR1 exon 6, leading to the p.Asp351Gly missense mutation, and chromatogram of Patient 2 showing the heterozygous c.1529T>G transversion in TGFBR2 exon 7, resulting in the p.Ile510Ser missense mutation. B) The p.Asp351Gly and p.Ile510Ser mutations substitute in LDS patients an aspartic acid and an isoleucine residues that are evolutionally conserved in TGFBR1 and TGFBR2 orthologues, respectively. Multiple sequence alignment was performed using CLUSTALW and PolyPhen.
###end p 20
###begin p 21
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">habitus </italic>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1017 1018 1017 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 193 200 <span type="species:ncbi:9606">Patient</span>
###xml 225 233 <span type="species:ncbi:405018">cardinal</span>
###xml 505 512 <span type="species:ncbi:9606">Patient</span>
###xml 649 657 <span type="species:ncbi:9606">patients</span>
###xml 722 729 <span type="species:ncbi:9606">Patient</span>
###xml 912 920 <span type="species:ncbi:9606">patients</span>
###xml 1055 1062 <span type="species:ncbi:9606">Patient</span>
Patient 1 showed suggestive signs (i.e., marfanoid habitus without fulfilled Ghent criteria for MFS, facial, skeletal, cutaneous and cardiovascular involvement) consistent with LDSI phenotype. Patient 2 showed the absence of cardinal features of LDS, such as arterial tortuosity, bifid uvula, hypertelorism, micrognathia, and joint hypermobility. These observations, associated with the presence of translucent skin and of marked venous varicosities, are consistent with a LDSII phenotype. In particular, Patient 2 resembled vEDS for skin presentation and joint involvement, that generally is less evident in vEDS than in other EDS types and in LDS patients [2]. However, the straight involvement of the thoracic aorta of Patient 2 is more suggestive of an LDS rather than a vEDS phenotype, since in vEDS the medium-sized arteries are more frequently affected than aorta and great vessels [14]. So far, 21 LDSII patients were reported, some of which did not show aortic root dilatation, arterial tortuosity, or both [2,13,15]. Remarkably, the daughter of Patient 2 showed at 26 years few disease signs, supporting previous observations in LDS intrafamiliar variability.
###end p 21
###begin p 22
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR</italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR</italic>
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR</italic>
###xml 288 298 288 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">continuum </italic>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 638 646 638 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 936 944 936 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC2A10 </italic>
###xml 1063 1064 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1067 1068 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1294 1295 1294 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1296 1297 1296 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1298 1300 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1516 1517 1516 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1518 1519 1518 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1520 1521 1520 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1522 1524 1522 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1525 1527 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1502 1508 <span type="species:ncbi:10090">murine</span>
In the TGFBRs-related disorders no genotype-phenotype correlation has been drawn, and the prediction of the clinical effects of different TGFBRs mutations remains difficult to envisage [1,9]. All the clinical entities caused by mutations in TGFBRs genes should be considered a phenotypic continuum of the same disease, ranging from isolated thoracic aneurysm to syndromic vascular rupture, and LDS should be considered a complex syndrome characterized by full penetrance (with very rare exceptions) [2], marked variable intra- and inter-familiar expressivity, allelic and genetic heterogeneity, pleiotropic effects, and high incidence of de novo events. On the other hand, LDS shows marked overlapping signs with other connective tissue disorders, due to different gene defects and characterized by vascular fragility, such as MFS (MIM 154700), vEDS (MIM 130050), and arterial tortuosity syndrome (ATS, MIM 208050), due to mutations in SLC2A10 gene and characterized by facial features, aneurysm ruptures, great vessels tortuosity, and pulmonary artery stenosis [1,2,6,13,16]. The allelic heterogeneity, as well as the clinical overlapping, could be related to the underlying pathophysiology of LDS, MFS, and MFS2 syndromes, and probably ATS, sharing alterations in similar molecular pathways [1,2,16]. Indeed, in these disorders, aortic aneurysm is associated with altered collagens deposition, elastic fibers disarray, and increased TGFbeta signalling, and is prevented by TGFbeta antagonists in the murine model [1,2,5,16,17].
###end p 22
###begin title 23
Conclusion
###end title 23
###begin p 24
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR1 </italic>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR2 </italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:405018">cardinal</span>
We report two novel mutations in the TGFBR1 and TGFBR2 genes in two patients affected with LDS and showing marked phenotypic variability. Due to the difficulties in the clinical approach to a TGFBR-related disease, among patients with vascular involvement, with or without aortic root dilatation and LDS cardinal features, genotyping is mandatory to clarify the diagnosis, to assess the management and the prognosis, and to satisfy counselling issues.
###end p 24
###begin p 25
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGFBR</italic>
Further genotype-phenotype studies in these connective tissue disorders, together with the comprehension of the role of the genetic factors responsible of the arterial wall defects, will provide new insights in vascular diseases. The pathogenesis, as well as the phenotype of LDS, could be influenced by other genetic factors, either TGFBRs intragenic functional polymorphisms and different modifier genes, encoding for TGFbeta pathway proteins, or components of the vascular extracellular matrix.
###end p 25
###begin title 26
Consent
###end title 26
###begin p 27
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Written informed consent was obtained from patients for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
###end p 27
###begin title 28
List of abbreviation used
###end title 28
###begin p 29
LDS: Loeys-Dietz syndrome; LDSI: LDS type I; LDSII: LDS type II; TGFBR1: transforming growth factor beta receptor 1; TGFBR2: transforming growth factor beta receptor 2; TGF: transforming growth factor; MFS: Marfan syndrome; vEDS: vascular Ehlers-Danlos syndrome; FS: Furlong syndrome; TAAD: familial thoracic aortic aneurysms and dissection: MRA: Magnetic Resonance Angiography.
###end p 29
###begin title 30
Competing interests
###end title 30
###begin p 31
The authors declare that they have no competing interests.
###end p 31
###begin title 32
Authors' contributions
###end title 32
###begin p 33
###xml 169 177 <span type="species:ncbi:9606">patients</span>
MC conceived the study. BD and MR carried out the molecular analysis, researched the literature reviewed and prepared the manuscript. AW, RF, BD, and PGCP diagnosed the patients and drafted the initial manuscript. AW, RF, NZ, and PGC-P contributed to the discussion section. SB and MC edited and coordinated the manuscript. All authors read and approved the final manuscript.
###end p 33
###begin title 34
Acknowledgements
###end title 34
###begin p 35
This work was supported by Fondazione Cariplo "ZebraGene" Grant 2007 and Ministero dell'Istruzione dell'Universita e della Ricerca, Fondo per gli investimenti della Ricerca di Base 2008.
###end p 35
###begin article-title 36
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
###end article-title 36
###begin article-title 37
Aneurysm syndromes caused by mutations in the TGF-beta receptor
###end article-title 37
###begin article-title 38
Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders
###end article-title 38
###begin article-title 39
FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited
###end article-title 39
###begin article-title 40
###xml 31 39 <span type="species:ncbi:9606">patients</span>
TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome
###end article-title 40
###begin article-title 41
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes
###end article-title 41
###begin article-title 42
Recent progress in genetics of Marfan syndrome and Marfan-associated disorders
###end article-title 42
###begin article-title 43
Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2
###end article-title 43
###begin article-title 44
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders
###end article-title 44
###begin article-title 45
Signal transduction by members of the transforming growth factor-beta superfamily
###end article-title 45
###begin article-title 46
Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-beta receptor genes
###end article-title 46
###begin article-title 47
Severe aortic and arterial aneurysms associated with a TGFBR2 mutation
###end article-title 47
###begin article-title 48
###xml 76 83 <span type="species:ncbi:9606">patient</span>
Identification of a novel TGFBR1 mutation in a Loeys-Dietz syndrome type II patient with vascular Ehlers-Danlos syndrome phenotype
###end article-title 48
###begin article-title 49
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
###end article-title 49
###begin article-title 50
Evolution of the face in Loeys-Dietz syndrome type II: longitudinal observations from infancy in seven cases
###end article-title 50
###begin article-title 51
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome
###end article-title 51
###begin article-title 52
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
###end article-title 52

